Marken has developed a specialized distribution service for the orphan drug market for the delivery of clinical trial drugs directly to a patient’s home or a remote clinic. The company also released a white paper for supply chain solutions for this growing market.   The production of orphan drugs, used to treat rare diseases, is increasing and will continue to rise with a compound annual growth rate of more than 7% per year between 2012 and 2018, according to the paper. Large pharma compan...